Evidence map›Paper›PMID 27464265›Full record

ArticleDiabetes/metabolism research and reviews2016

Standards of care for type 2 diabetes in China.

Jianping Weng, Linong Ji, Weiping Jia, Juming Lu, Zhiguang Zhou, Dajin Zou, Dalong Zhu, Liming Chen, Li Chen, Lixin Guo and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes/metabolism research and reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 166 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
166citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

166 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article

106 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Jianping WengDepartment of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Linong JiDepartment of Endocrinology, Peking University People's Hospital, Beijing, China.
Weiping JiaShanghai Diabetes Institute, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Juming LuDepartment of Endocrinology, Chinese People's Liberation Army General Hospital, Beijing, China.
Zhiguang ZhouInstitute of Metabolism and Endocrinology, Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases, The Second Xiangya Hospital and the Diabetes Center, Central South University, Changsha, China.
Dajin ZouDepartment of Endocrinology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Dalong ZhuDepartment of Endocrinology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Liming ChenTianjin Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Li ChenDepartment of Endocrinology, Qilu Hospital of Shandong University, Ji'nan, China.
Lixin GuoDepartment of Endocrinology, Beijing Hospital, Beijing, China.
Xiaohui GuoDepartment of Endocrinology, Peking University First Hospital, Beijing, China.
Qiuhe JiDepartment of Endocrinology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Qifu LiDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiaoying LiDepartment of Endocrinology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jing LiuDepartment of Endocrinology, Gansu Provincial Hospital, Lanzhou, China.
Xingwu RanDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
Zhongyan ShanDepartment of Endocrinology, The First Hospital of China Medical University, Shenyang, China.
Lixin ShiDepartment of Endocrinology, Affiliated Hospital of Guiyang Medical University, Guiyang, China.
Guangyao SongDepartment of Endocrinology, Hebei General Hospital, Shijiazhuang, China.
Liyong YangDepartment of Endocrinology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Yuzhi YangDepartment of Endocrinology, Heilongjiang Provincial Hospital, Harbin, China.
Wenying YangDepartment of Endocrinology, China Japan Friendship Hospital, Beijing, China.
Chinese Diabetes Society

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedBlood GlucoseChinaDiabetes ComplicationsDiabetes Mellitus, Type 2ExerciseHumansHypertensionHypoglycemic AgentsLife StyleMiddle AgedNutrition TherapyPractice Guidelines as TopicRisk FactorsStandard of CareBlood GlucoseHypoglycemic Agents

Identifiers

PMID27464265
PMCPMC5108436

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.